Behind The Money with the Financial Times-logo

Behind The Money with the Financial Times

Business & Economics Podcasts >

From hostile takeovers to C-suite intrigue, Behind The Money takes you inside the big business and financial stories of the moment with reporting from Financial Times journalists around the world. New episodes released on Tuesdays. Hosted by Aimee Keane.

From hostile takeovers to C-suite intrigue, Behind The Money takes you inside the big business and financial stories of the moment with reporting from Financial Times journalists around the world. New episodes released on Tuesdays. Hosted by Aimee Keane.
More Information


United States


From hostile takeovers to C-suite intrigue, Behind The Money takes you inside the big business and financial stories of the moment with reporting from Financial Times journalists around the world. New episodes released on Tuesdays. Hosted by Aimee Keane.




What next for Detroit's carmakers

The future is on the line again for the carmakers known as the "big three": Ford, GM and what is now Fiat Chrysler. Ten years ago the question was whether the carmakers would survive the financial crisis. Today, investors wonder if traditional car companies will be able to make the technological shift to an industry of self-driving, electric and service-focused cars. The FT’s Patti Waldmeir reports.


Pharma raises its bet on biotech

In the past month pharmaceutical companies have spent almost $100bn acquiring biotech companies. The FT's Sarah Neville explains why big pharma is raising its bet on the drug pipelines owned by biotechs, and why analysts expect more consolidation in 2019. Read more from Sarah at


China's Didi adds finance to the mix

In 2017, the Chinese ride-hailing app was the highest valued start-up in the world at $56bn. But after a difficult period in 2018 following the murder of two passengers on its platform and a government crackdown, Didi has made a move to diversify by offering financial services. The FT's Yuan Yang reports.


Huawei and the fight for 5G

The arrest of Meng Wanzhou, Huawei's chief financial officer, followed months of mounting scrutiny of the world's biggest telecoms equipment maker. The FT's Nic Fildes explains how Huawei grew to be such a big player, and why western intelligence officials are warning against working with the Chinese company on the next generation of mobile technology.


IBM's next move

In October, IBM announced it would acquire open source software pioneer Red Hat for $34bn. The deal resonated with Wall Street, but making the two companies work together will be another challenge. The FT’s Richard Waters digs into IBM's history and what its tie-up with Red Hat signals about the future.


The oil sell-off explained

Oil prices plunged below $63 a barrel on Tuesday after weeks of steady declines. The FT's Anjli Raval explains what is behind the souring mood among investors.


Investors fear 'peak iPhone'

Apple shares have taken a hit this month amid fears that demand for the iPhone has peaked. Tim Bradshaw explains what is worrying investors.


How €200bn of ‘dirty money’ flowed through a Danish bank

How did Denmark’s Danske Bank find itself at the centre of one of the largest money laundering scandals the world has ever seen? The FT’s Richard Milne explains.


The future of dealmaking with Saudi Arabia

Some of the world’s most influential financiers and executives have spent the past three years courting Saudi Arabia’s dealmaker-in-chief Mohammed bin Salman and his $300bn state investment fund. But the disappearance of Saudi journalist Jamal Khashoggi has turned the pursuit of trophy deals into an exercise in crisis management. The FT's Arash Massoudi explains how the crown prince sought to modernise the Saudi economy with support of the global business elite, and what the future holds for...


The rise and fall of General Electric

GE is one of the greatest names in American business. It was an original member of the Dow Jones Industrial Average, and at its peak the industrial conglomerate had a market capitalisation of nearly $600bn. But after decades of dealmaking, a weakening power sector is forcing the group's executives to consider radical changes. The FT's Ed Crooks explains. Review clips: Bloomberg, CNBC, Fox Business Network, PBS News, Euro News.


Tune in Wednesday

This week's episode of Behind The Money will be available on Wednesday morning, instead of our usual time on Tuesday. Be sure to check back Wednesday morning for a brand episode.


Private equity's debt mountain (encore episode)

Private equity has flooded the deal market in recent years, in part due to an era of cheap debt and fund managers on the hunt for greater investment returns. Firms are scooping up stakes in oil pipelines and newspapers — and even dental clinics. With a record $1.8tn in pension and sovereign wealth fund money waiting to be invested, some analysts are asking when private equity’s winning run will come to an end. With the FT's Javier Espinoza. Read more here. Review clips: CNBC, NBC, Bloomberg.


Tilray and the cannabis trade

The Canadian company was the first cannabis producer to make an initial public offering on a US stock exchange, and, after a week of volatile trading, some analysts are asking if investor excitement has gotten ahead of reality. The FT's Nicole Bullock explains. Review clips: Fox Business Network, ABC, CBS, BNN Bloomberg, CNBC, Bloomberg. Music by Podington Bear.


On the front lines of the crisis

Nick was a regulator at the London Stock Exchange. Julia was an entrepreneur whose home was foreclosed. Ten years on from the collapse of Lehman Brothers we talk to two people with different perspectives on the lessons of the global financial crisis. Review clips: AP, CBS.


Purdue Pharma's 'one-two' punch

The name “Sackler” adorns museums and art galleries around the world. But the family name has also become tainted by its association with the US opioid crisis, amid accusations that OxyContin, more than any other drug, is responsible for sparking one of the worst public health epidemics of modern times. The FT's David Crow explains how the Sackler family company Purdue Pharma got its hold on the opioid market.


Following the cannabis money trail (encore episode)

Medical marijuana is legal in 21 countries. In Canada, residents expect they will be able to buy cannabis from dispensaries and pharmacies across the country later this year. Some analysts have valued the legal business at anywhere between $7bn-$20bn, attracting a host of entrepreneurs and investors trying to get in on the action before the market takes off. We talk to two entrepreneurs with two very different plans to capitalise on the boom. This episode was originally published on June...


Khosrowshahi's year at the wheel

A little more than a year ago, Uber's board was in search of a new chief executive. Co-founder Travis Kalanick had resigned from the top job amid allegations of a toxic and sexist company culture, and the board was looking for someone to fix the group's operations and ready it for what is expected to be the tech world's biggest public offering. Behind The Money looks at Dara Khosrowshahi's first year at the helm. With the FT's Shannon Bond. Review clips: ABC News, WSJ, NBC News, CBS News,...


Digging into student debt

The amount of outstanding student debt in the US has hit a staggering $1.4tn, and many millennials say the education-related debt they've been saddled with has prevented them from doing things like buying a home, getting married and taking career risks. Who has been hit the hardest by student debt loads and what does it mean for the US economy? With guests Michael Ranalli, Judith Scott-Clayton and the FT's Sam Fleming. Read more of Sam's reporting at Review clips: Fox Business...


Taking Tesla private

What is behind Elon Musk's plan to take the electric carmaker private, and who will provide the funding? The FT's Arash Massoudi explains the story that has unfolded since the chief executive posted his "funding secured" tweet. Read more here. Review clips: CityTV, CNBC, MSNBC, Bloomberg.


Tesla’s rough ride

Elon Musk's grand vision for the electric carmaker has drawn dedicated fans and followers. But Tesla has also tested the patience of customers and investors after a hit-and-miss on production targets while burning through cash. What will it take for Tesla to become a stable and profitable car manufacturer? The FT’s Richard Waters examines its prospects. Read more here.